Antinuclear Antibodies May Predict the Development of Immune-Related Adverse Events in Asymptomatic Patients Treated with Immune Checkpoint Inhibitors: Results from a Single-Center Cohort
Clinical and Experimental Medicine(2024)
Key words
Immune-checkpoints inhibitors,Anti-nuclear antibodies,Adverse events,Biomarkers
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined